Steroid use in HCV-infected liver transplant recipients

被引：0
|
作者：
Bruno Roche
Didier Samuel
机构：
[1] AP-HP Hôpital Paul Brousse,
[2] Centre Hépato-Biliaire,undefined
[3] Université Paris-Sud UMR-S 785,undefined
[4] and INSERM U 785,undefined
来源：
Nature Reviews Gastroenterology & Hepatology | 2009年 / 6卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The recurrence of hepatitis C in HCV-infected, orthotopic liver transplant recipients is a major problem that can influence the survival of both grafted tissue and patients. Yet the effects of immunosuppression strategies, in particular those of steroids, on disease recurrence remain unclear.
引用
收藏
页码：198 / 200
页数：2
相关论文
共 50 条
  • [41] Allogeneic hematopoietic cell transplant in HCV-infected patients
    de Latour, Regis Peffault
    Ribaud, Patricia
    Robin, Marie
    Valla, Dominique
    Marcellin, Patrick
    Socie, Gerard
    Asselah, Tarik
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (06) : 1008 - 1017
  • [42] Management and treatment of the HCV-infected kidney transplant patient
    Wong, Tiffany
    Bloom, Roy D.
    [J]. SEMINARS IN DIALYSIS, 2019, 32 (02) : 169 - 178
  • [43] HAART and the HCV-infected liver: friend or foe?
    Sulkowski, MS
    [J]. JOURNAL OF HEPATOLOGY, 2004, 41 (01) : 181 - 184
  • [44] Lack of effect of CMV reactivation in the outcome of HCV-infected liver transplant(LT)patients
    Aguilera, Victoria
    Di Maira, Tommaso
    Conde, Isabel
    Rubin, Angel
    Vinaixa, Carmen
    Benlloch, Salvador
    Prieto, Martin
    Berenguer, Marina
    [J]. HEPATOLOGY, 2015, 62 : 818A - 818A
  • [45] Lack of Effect of CMV Reactivation in the Outcome of HCV-Infected Liver Transplant(LT) Patients
    Aguilera, Victoria
    Di Maira, Tommaso
    Yesmembetov, Kakharman
    Vinaixa, Carmen
    Garcia, Maria
    Benlloch, Salvador
    Rubin, Angel
    Berenguer, Marina
    Prieto, Martin
    [J]. TRANSPLANTATION, 2015, 99 : 165 - 165
  • [46] Lung Transplantation from HCV-Infected Donors to HCV-Uninfected Recipients
    Feld, Jordan J.
    Humar, Atul
    Singer, Lianne
    Kumar, Deepali
    Bahinskaya, Ilona
    Kuczynski, Magdalena
    Waddell, Thomas
    Keshavjee, Shaf
    Cyprel, Marcelo
    [J]. HEPATOLOGY, 2018, 68 : 139A - 140A
  • [47] HCV-Infected donor indices and the course of acute hepatitis in their recipients
    Mosley, JW
    Operskalski, EA
    Rawal, BD
    Fiebig, EW
    Busch, MP
    [J]. TRANSFUSION, 2001, 41 (09) : 76S - 77S
  • [48] DACLATASVIR PLUS SOFOSBUVIR FOR CHRONIC HCV-INFECTED KIDNEY TRANSPLANT RECIPIENTS - A PILOT STUDY OF EFFICACY AND SAFETY
    Duerr, M.
    Staeck, O.
    Khadzhynov, D.
    Schrezenmeier, E.
    Lehner, L.
    Budde, K.
    Halleck, F.
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 : 20 - 20
  • [49] Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients
    Adenugba, Akinbami
    Hornung, Matthias
    Weigand, Kilian
    Peschel, Georg
    Junger, Henrik
    Kupke, Paul
    Lang, Hauke
    Marquardt, Jens U.
    Zimmermann, Tim
    Geissler, Edward K.
    Schlitt, Hans J.
    Werner, Jens M.
    [J]. TRANSPLANTATION, 2021, 105 (10) : 2226 - 2238
  • [50] Transplantation of HCV-infected organs into uninfected recipients: Advance with caution
    Wadei, Hani M.
    Pungpapong, Surakit
    Cortese, Cherise
    Alexander, Mariam P.
    Keaveny, Andrew P.
    Yang, Liu
    Taner, C. Burcin
    Croome, Kristopher P.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 (03) : 960 - 961
12345